Amgen Inc (NASDAQ: AMGN)

DRUGS - Biotechnology

Health Care

Stock price data as of

Closing price: $385.65
  • Support level
    $353.87
  • Resistance level
    $405.91
  • Beta
    0.4
  • RSI (14-day)
    27.4
  • AMGN is one of this month's worst performers with a return of -11.1 percent, underperforming 90 percent of stocks in the S&P-100.
  • Volatility is forecast to fall over the next month.
  • AMGN is above its 200-day moving average, providing a measure of support for long positions.
  • With RSI < 30, AMGN is oversold. Odds slightly favor a short-term price reversal.

52-week range
52-week low 52-week high Price as % of range
$271.18 $444.12 71.4%

Moving averages
200 day 50 day 20 day 10 day
$360.35 $400.27 $413.53 $388.04

Value at risk (VaR)

There is an estimated 5% probability that the stock price will fall by more than VaR in time period.

  • In the next week
    6.4%
  • In the next month
    13.8%
  • In the next year
    56.3%

Volatility estimates (annualized standard deviations)
Period Value
Historical (5 year) 24.7%
Last month 29.1%
Current estimate 23.4%
Next month forecast 24.5%